460 related articles for article (PubMed ID: 26521111)
21. Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review Recipients.
Dong X; Tsang CCS; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
Explor Res Clin Soc Pharm; 2021 Sep; 3():. PubMed ID: 35434697
[TBL] [Abstract][Full Text] [Related]
22. Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System.
de Oliveira DR; Brummel AR; Miller DB
J Manag Care Spec Pharm; 2020 Sep; 26(9):1057-1066. PubMed ID: 32857651
[TBL] [Abstract][Full Text] [Related]
23. Solving racial/ethnic disparities associated with Medicare Part D Star Ratings.
Dong X; Tsang CCS; Browning JA; Sim Y; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J
Curr Med Res Opin; 2023 Jul; 39(7):963-971. PubMed ID: 37219396
[TBL] [Abstract][Full Text] [Related]
24. Racial and ethnic disparities associated with the measure for drug-drug interactions among Medicare beneficiaries.
Browning J; Tsang CCS; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Dong X; Wang J
J Am Pharm Assoc (2003); 2022; 62(1):142-149. PubMed ID: 34509379
[TBL] [Abstract][Full Text] [Related]
25. Changes in Racial and Ethnic Disparities in Access to Care and Health Among US Adults at Age 65 Years.
Wallace J; Jiang K; Goldsmith-Pinkham P; Song Z
JAMA Intern Med; 2021 Sep; 181(9):1207-1215. PubMed ID: 34309621
[TBL] [Abstract][Full Text] [Related]
26. Racial and ethnic disparities in the enrolment of medicare medication therapy management programs.
Garuccio J; Tsang CCS; Wan JY; Shih YCT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Dong X; Browning JA; Zeng R; Wang J
J Pharm Health Serv Res; 2023 Jun; 14(2):188-197. PubMed ID: 37337596
[TBL] [Abstract][Full Text] [Related]
27. Exploring racial and ethnic disparities in prescription drug spending and use among Medicare beneficiaries.
Gaskin DJ; Briesacher BA; Limcangco R; Brigantti BL
Am J Geriatr Pharmacother; 2006 Jun; 4(2):96-111. PubMed ID: 16860257
[TBL] [Abstract][Full Text] [Related]
28. Racial and ethnic disparities in Medicare Part D medication therapy management services utilization.
Dong X; Tsang CCS; Browning JA; Garuccio J; Wan JY; Shih YCT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J; Wang J
Explor Res Clin Soc Pharm; 2023 Mar; 9():100222. PubMed ID: 36712831
[TBL] [Abstract][Full Text] [Related]
29. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
[TBL] [Abstract][Full Text] [Related]
30. Medication therapy management: 10 years of experience in a large integrated health care system.
Ramalho de Oliveira D; Brummel AR; Miller DB
J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence.
Ferries E; Dye JT; Hall B; Ndehi L; Schwab P; Vaccaro J
J Manag Care Spec Pharm; 2019 Jun; 25(6):688-695. PubMed ID: 31134865
[TBL] [Abstract][Full Text] [Related]
32. Should eligibility for medication therapy management be based on drug adherence?
Stuart B; Loh E; Miller L; Roberto P
J Manag Care Pharm; 2014 Jan; 20(1):66-75. PubMed ID: 24511767
[TBL] [Abstract][Full Text] [Related]
33. Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries.
Almodóvar AS; Nahata MC
J Manag Care Spec Pharm; 2019 May; 25(5):573-577. PubMed ID: 31039057
[TBL] [Abstract][Full Text] [Related]
34. Economic assessment of changes to an existing medication therapy management program of a large regional health plan.
Peasah SK; Hammonds T; Liu Y; Campbell V; Manolis C; Good CB
J Manag Care Spec Pharm; 2021 Feb; 27(2):147-156. PubMed ID: 33506728
[No Abstract] [Full Text] [Related]
35. Racial and Ethnic Disparities in Health Care Use and Access Associated With Loss of Medicaid Supplemental Insurance Eligibility Above the Federal Poverty Level.
Roberts ET; Kwon Y; Hames AG; McWilliams JM; Ayanian JZ; Tipirneni R
JAMA Intern Med; 2023 Jun; 183(6):534-543. PubMed ID: 37036727
[TBL] [Abstract][Full Text] [Related]
36. Cost-Effectiveness of Medication Therapy Management Program Across Racial and Ethnic Groups Among Medicare Beneficiaries.
Tsang CCS; Shih YT; Dong X; Garuccio J; Browning JA; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Zeng R; Wang J
Value Health; 2023 May; 26(5):649-657. PubMed ID: 36376143
[TBL] [Abstract][Full Text] [Related]
37. Assessing Medicare Beneficiary Eligibility for Medication Therapy Management Programs Using PINNACLE, a National Cardiovascular Data Registry.
Spinler SA; Cziraky MJ; Tang F; Dueñas GG; Thomas T; Reinhold JA; Willey VJ
Am Health Drug Benefits; 2013 Sep; 6(7):367-74. PubMed ID: 24991369
[TBL] [Abstract][Full Text] [Related]
38. Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program.
Allen A; Hung A
J Manag Care Spec Pharm; 2024 Jun; 30(6):609-616. PubMed ID: 38824629
[TBL] [Abstract][Full Text] [Related]
39. Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.
Steve Tsang CC; Wan JY; Chisholm-Burns MA; Li M; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
Res Social Adm Pharm; 2021 Aug; 17(8):1469-1477. PubMed ID: 33272859
[TBL] [Abstract][Full Text] [Related]
40. Racial disparities in prescription drug use for mental illness among population in US.
Han E; Liu GG
J Ment Health Policy Econ; 2005 Sep; 8(3):131-43. PubMed ID: 16278501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
